{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:47:37Z","timestamp":1794469657714,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Spreading of aggregate pathology across brain regions acts as a driver of disease progression in Tau-related neurodegeneration, including Alzheimer\u2019s disease (AD) and frontotemporal dementia. Aggregate seeds released from affected cells are internalized by na\u00efve cells and induce the prion-like templating of soluble Tau into neurotoxic aggregates. Here we show in a cellular model system and in neurons that Clusterin, an abundant extracellular chaperone, strongly enhances Tau aggregate seeding. Upon interaction with Tau aggregates, Clusterin stabilizes highly potent, soluble seed species. Tau\/Clusterin complexes enter recipient cells via endocytosis and compromise the endolysosomal compartment, allowing transfer to the cytosol where they propagate aggregation of endogenous Tau. Thus, upregulation of Clusterin, as observed in AD patients, may enhance Tau seeding and possibly accelerate the spreading of Tau pathology.<\/jats:p>","DOI":"10.1038\/s41467-021-25060-1","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T06:09:03Z","timestamp":1628662143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-3849","authenticated-orcid":false,"given":"Patricia","family":"Yuste-Checa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Trinkaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-3921","authenticated-orcid":false,"given":"Irene","family":"Riera-Tur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-8317","authenticated-orcid":false,"given":"Rahmi","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-7823","authenticated-orcid":false,"given":"Theresa F.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-5355","authenticated-orcid":false,"given":"Huping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-8485","authenticated-orcid":false,"given":"Irina","family":"Dudanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-3016","authenticated-orcid":false,"given":"Mark S.","family":"Hipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-7594","authenticated-orcid":false,"given":"Andreas","family":"Bracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-135X","authenticated-orcid":false,"given":"F. Ulrich","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"25060_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199\u2013212 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"25060_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker, M. & Walker, L. C. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat. Neurosci. 21, 1341\u20131349 (2018).","journal-title":"Nat. Neurosci."},{"key":"25060_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","volume":"88","author":"J Vaquer-Alicea","year":"2019","unstructured":"Vaquer-Alicea, J. & Diamond, M. I. Propagation of protein aggregation in neurodegenerative diseases. Annu. Rev. Biochem. 88, 785\u2013810 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"25060_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755\u2013773 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25060_CR5","doi-asserted-by":"publisher","unstructured":"Sibilla, C. & Bertolotti, A. Prion properties of SOD1 in amyotrophic lateral sclerosis and potential therapy. Cold Spring Harb Perspect Biol 9, https:\/\/doi.org\/10.1101\/cshperspect.a024141 (2017).","DOI":"10.1101\/cshperspect.a024141"},{"key":"25060_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. The release and trans-synaptic transmission of Tau via exosomes. Mol. Neurodegener. 12, 5 (2017).","journal-title":"Mol. Neurodegener."},{"key":"25060_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello, C. A., Merezhko, M., Uronen, R. L. & Huttunen, H. J. Mechanisms of secretion and spreading of pathological tau protein. Cell Mol. Life Sci. 77, 1721\u20131744 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"25060_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnagi.2020.00268","volume":"12","author":"K Chaplot","year":"2020","unstructured":"Chaplot, K., Jarvela, T. S. & Lindberg, I. Secreted chaperones in neurodegeneration. Front Aging Neurosci. 12, 268 (2020).","journal-title":"Front Aging Neurosci."},{"key":"25060_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M. & Buckley, N. J. Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front. Neurosci. 13, 164 (2019).","journal-title":"Front. Neurosci."},{"key":"25060_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-072711-163904","volume":"82","author":"AR Wyatt","year":"2013","unstructured":"Wyatt, A. R., Yerbury, J. J., Ecroyd, H. & Wilson, M. R. Extracellular chaperones and proteostasis. Annu Rev. Biochem 82, 295\u2013322 (2013).","journal-title":"Annu Rev. Biochem"},{"key":"25060_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbrc.2009.07.166","volume":"388","author":"KW Lee","year":"2009","unstructured":"Lee, K. W. et al. Clusterin regulates transthyretin amyloidosis. Biochem. Biophys. Res. Commun. 388, 256\u2013260 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"25060_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nsmb.2191","volume":"19","author":"P Narayan","year":"2011","unstructured":"Narayan, P. et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide. Nat. Struct. Mol. Biol. 19, 79\u201383 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"25060_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"JM Gregory","year":"2017","unstructured":"Gregory, J. M. et al. Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol. Commun. 5, 81 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"25060_CR14","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury, J. J. et al. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21, 2312\u20132322 (2007).","journal-title":"FASEB J."},{"key":"25060_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"JT Yu","year":"2012","unstructured":"Yu, J. T. & Tan, L. The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol. Neurobiol. 45, 314\u2013326 (2012).","journal-title":"Mol. Neurobiol."},{"key":"25060_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"25060_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"25060_CR18","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos, R. B. et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 99, 10843\u201310848 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR19","doi-asserted-by":"publisher","first-page":"E6962","DOI":"10.1073\/pnas.1701137114","volume":"114","author":"AM Wojtas","year":"2017","unstructured":"Wojtas, A. M. et al. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc. Natl Acad. Sci. USA 114, E6962\u2013E6971 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"SB Oh","year":"2019","unstructured":"Oh, S. B. et al. Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol. 29, 217\u2013231 (2019).","journal-title":"Brain Pathol."},{"key":"25060_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-018-0402-7","volume":"19","author":"XM Qi","year":"2018","unstructured":"Qi, X. M., Wang, C., Chu, X. K., Li, G. & Ma, J. F. Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer\u2019s disease. BMC Neurosci. 19, 2 (2018).","journal-title":"BMC Neurosci."},{"key":"25060_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15215-w","volume":"7","author":"S Fernandez-de-Retana","year":"2017","unstructured":"Fernandez-de-Retana, S. et al. Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral beta-amyloidosis. Sci. Rep. 7, 14637 (2017).","journal-title":"Sci. Rep."},{"key":"25060_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bcp.2018.07.012","volume":"155","author":"L Montoliu-Gaya","year":"2018","unstructured":"Montoliu-Gaya, L. et al. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Abeta scFv in 3xTg-AD mice. Biochem. Pharm. 155, 380\u2013392 (2018).","journal-title":"Biochem. Pharm."},{"key":"25060_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/mp.2012.163","volume":"19","author":"R Killick","year":"2014","unstructured":"Killick, R. et al. Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol. Psychiatry 19, 88\u201398 (2014).","journal-title":"Mol. Psychiatry"},{"key":"25060_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fnins.2018.00504","volume":"12","author":"JP Robbins","year":"2018","unstructured":"Robbins, J. P. et al. Clusterin is required for beta-amyloid toxicity in human iPSC-derived neurons. Front Neurosci. 12, 504 (2018).","journal-title":"Front Neurosci."},{"key":"25060_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","volume":"5","author":"PC May","year":"1990","unstructured":"May, P. C. et al. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat. Neuron 5, 831\u2013839 (1990).","journal-title":"Neuron"},{"key":"25060_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","volume":"48","author":"AM Nilselid","year":"2006","unstructured":"Nilselid, A. M. et al. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int. 48, 718\u2013728 (2006).","journal-title":"Neurochem Int."},{"key":"25060_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF00296787","volume":"83","author":"NH Choi-Miura","year":"1992","unstructured":"Choi-Miura, N. H. et al. SP-40,40 is a constituent of Alzheimer\u2019s amyloid. Acta Neuropathol. 83, 260\u2013264 (1992).","journal-title":"Acta Neuropathol."},{"key":"25060_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0006-8993(92)90071-G","volume":"579","author":"PL McGeer","year":"1992","unstructured":"McGeer, P. L., Kawamata, T. & Walker, D. G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579, 337\u2013341 (1992).","journal-title":"Brain Res."},{"key":"25060_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s004010050815","volume":"95","author":"P Giannakopoulos","year":"1998","unstructured":"Giannakopoulos, P. et al. Possible neuroprotective role of clusterin in Alzheimer\u2019s disease: a quantitative immunocytochemical study. Acta Neuropathol. 95, 387\u2013394 (1998).","journal-title":"Acta Neuropathol."},{"key":"25060_CR31","doi-asserted-by":"publisher","unstructured":"Itakura, E., Chiba, M., Murata, T. & Matsuura, A. Heparan sulfate is a clearance receptor for aberrant extracellular proteins. J Cell Biol 219, https:\/\/doi.org\/10.1083\/jcb.201911126 (2020).","DOI":"10.1083\/jcb.201911126"},{"key":"25060_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"25060_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell, R. D. et al. Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow. Metab. 27, 909\u2013918 (2007).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"25060_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty, M. et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 67, 739\u2013748 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"25060_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EM Schrijvers","year":"2011","unstructured":"Schrijvers, E. M., Koudstaal, P. J., Hofman, A. & Breteler, M. M. Plasma clusterin and the risk of Alzheimer disease. JAMA 305, 1322\u20131326 (2011).","journal-title":"JAMA"},{"key":"25060_CR36","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70, 960\u2013969 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"25060_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. & Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42, 631\u2013639 (1992).","journal-title":"Neurology"},{"key":"25060_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson, P. T. et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362\u2013381 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"25060_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","volume":"29","author":"YC Hsieh","year":"2019","unstructured":"Hsieh, Y. C. et al. Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer\u2019s disease. Cell Rep. 29, 301\u2013316 e310 (2019).","journal-title":"Cell Rep."},{"key":"25060_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas, A. M. et al. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol. Commun. 8, 210 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"25060_CR41","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl Acad. Sci. USA 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR42","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.1021\/bi026469j","volume":"41","author":"S Barghorn","year":"2002","unstructured":"Barghorn, S. & Mandelkow, E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41, 14885\u201314896 (2002).","journal-title":"Biochemistry"},{"key":"25060_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbadis.2004.09.010","volume":"1739","author":"M von Bergen","year":"2005","unstructured":"von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158\u2013166 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"25060_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","volume":"64","author":"SH Scheres","year":"2020","unstructured":"Scheres, S. H., Zhang, W., Falcon, B. & Goedert, M. Cryo-EM structures of tau filaments. Curr. Opin. Struct. Biol. 64, 17\u201325 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"25060_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/383550a0","volume":"383","author":"M Goedert","year":"1996","unstructured":"Goedert, M. et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550\u2013553 (1996).","journal-title":"Nature"},{"key":"25060_CR46","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1039\/C4CP05563B","volume":"17","author":"P Arosio","year":"2015","unstructured":"Arosio, P., Knowles, T. P. & Linse, S. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 17, 7606\u20137618 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"25060_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41594-018-0057-1","volume":"25","author":"SA Mok","year":"2018","unstructured":"Mok, S. A. et al. Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat. Struct. Mol. Biol. 25, 384\u2013393 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"25060_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal, K., Liu, F. & Gong, C. X. Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12, 15\u201327 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"25060_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert, M., Jakes, R. & Vanmechelen, E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167\u2013169 (1995).","journal-title":"Neurosci. Lett."},{"key":"25060_CR50","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1073\/pnas.85.13.4884","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik, C. M. et al. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4884\u20134888 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR51","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin, S. et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat. Med. 26, 1256\u20131263 (2020).","journal-title":"Nat. Med."},{"key":"25060_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-981-32-9358-8_23","volume":"1184","author":"S Dujardin","year":"2019","unstructured":"Dujardin, S. & Hyman, B. T. Tau prion-like propagation: state of the art and current challenges. Adv. Exp. Med. Biol. 1184, 305\u2013325 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"25060_CR53","doi-asserted-by":"publisher","first-page":"20318","DOI":"10.1074\/jbc.M114.554725","volume":"289","author":"S Kumar","year":"2014","unstructured":"Kumar, S. et al. Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity. J. Biol. Chem. 289, 20318\u201320332 (2014).","journal-title":"J. Biol. Chem."},{"key":"25060_CR54","doi-asserted-by":"publisher","first-page":"18952","DOI":"10.1074\/jbc.RA119.009432","volume":"294","author":"JJ Chen","year":"2019","unstructured":"Chen, J. J. et al. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J. Biol. Chem. 294, 18952\u201318966 (2019).","journal-title":"J. Biol. Chem."},{"key":"25060_CR55","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1074\/jbc.M117.809293","volume":"293","author":"B Falcon","year":"2018","unstructured":"Falcon, B., Noad, J., McMahon, H., Randow, F. & Goedert, M. Galectin-8-mediated selective autophagy protects against seeded tau aggregation. J. Biol. Chem. 293, 2438\u20132451 (2018).","journal-title":"J. Biol. Chem."},{"key":"25060_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch, J. N. et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs). Sci. Rep. 8, 6382 (2018).","journal-title":"Sci. Rep."},{"key":"25060_CR57","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes, B. B. et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl Acad. Sci. USA 110, E3138\u2013E3147 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00401-017-1722-x","volume":"134","author":"WP Flavin","year":"2017","unstructured":"Flavin, W. P. et al. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins. Acta Neuropathol. 134, 629\u2013653 (2017).","journal-title":"Acta Neuropathol."},{"key":"25060_CR59","doi-asserted-by":"publisher","first-page":"17707","DOI":"10.1016\/S0021-9258(19)47429-2","volume":"266","author":"T Yoshimori","year":"1991","unstructured":"Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M. & Tashiro, Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266, 17707\u201317712 (1991).","journal-title":"J. Biol. Chem."},{"key":"25060_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1073\/pnas.87.1.83","volume":"87","author":"DL Thiele","year":"1990","unstructured":"Thiele, D. L. & Lipsky, P. E. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc. Natl Acad. Sci. USA 87, 83\u201387 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fcell.2018.00163","volume":"6","author":"SM Alavi Naini","year":"2018","unstructured":"Alavi Naini, S. M. & Soussi-Yanicostas, N. Heparan sulfate as a therapeutic target in tauopathies: insights from zebrafish. Front Cell Dev. Biol. 6, 163 (2018).","journal-title":"Front Cell Dev. Biol."},{"key":"25060_CR62","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.15252\/embj.201592484","volume":"34","author":"JH Hurley","year":"2015","unstructured":"Hurley, J. H. ESCRTs are everywhere. EMBO J. 34, 2398\u20132407 (2015).","journal-title":"EMBO J."},{"key":"25060_CR63","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature10744","volume":"482","author":"TL Thurston","year":"2012","unstructured":"Thurston, T. L., Wandel, M. P., von Muhlinen, N., Foeglein, A. & Randow, F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482, 414\u2013418 (2012).","journal-title":"Nature"},{"key":"25060_CR64","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1016\/j.celrep.2018.05.074","volume":"23","author":"DR Whiten","year":"2018","unstructured":"Whiten, D. R. et al. Single-molecule characterization of the interactions between extracellular chaperones and toxic alpha-synuclein oligomers. Cell Rep. 23, 3492\u20133500 (2018).","journal-title":"Cell Rep."},{"key":"25060_CR65","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.1074\/jbc.RA120.013478","volume":"295","author":"E Nachman","year":"2020","unstructured":"Nachman, E. et al. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J. Biol. Chem. 295, 9676\u20139690 (2020).","journal-title":"J. Biol. Chem."},{"key":"25060_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24716","volume":"80","author":"S Takeda","year":"2016","unstructured":"Takeda, S. et al. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer\u2019s disease mouse model and human patients. Ann. Neurol. 80, 355\u2013367 (2016).","journal-title":"Ann. Neurol."},{"key":"25060_CR67","doi-asserted-by":"publisher","unstructured":"Wang, C. et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron, https:\/\/doi.org\/10.1016\/j.neuron.2021.03.024 (2021).","DOI":"10.1016\/j.neuron.2021.03.024"},{"key":"25060_CR68","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk, A. et al. Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model. Ann. Neurol. 89, 952\u2013966 (2021).","journal-title":"Ann. Neurol."},{"key":"25060_CR69","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"25060_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao, N. et al. APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat. Commun. 9, 4388 (2018).","journal-title":"Nat. Commun."},{"key":"25060_CR71","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1210\/en.2013-1870","volume":"155","author":"MJ Kwon","year":"2014","unstructured":"Kwon, M. J. et al. Deficiency of clusterin exacerbates high-fat diet-induced insulin resistance in male mice. Endocrinology 155, 2089\u20132101 (2014).","journal-title":"Endocrinology"},{"key":"25060_CR72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos, R. B. et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41, 193\u2013202 (2004).","journal-title":"Neuron"},{"key":"25060_CR73","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1523\/JNEUROSCI.18-09-03180.1998","volume":"18","author":"DJ Stone","year":"1998","unstructured":"Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P. & Finch, C. E. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer\u2019s disease. J. Neurosci. 18, 3180\u20133185 (1998).","journal-title":"J. Neurosci."},{"key":"25060_CR74","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3233\/JAD-201162","volume":"80","author":"N An","year":"2021","unstructured":"An, N. et al. Synergistic effects of APOE and CLU may increase the risk of Alzheimer\u2019s disease: acceleration of atrophy in the volumes and shapes of the hippocampus and amygdala. J. Alzheimers Dis. 80, 1311\u20131327 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"25060_CR75","doi-asserted-by":"publisher","unstructured":"Lenzi, C. et al. The down-regulation of clusterin expression enhances the alphasynuclein aggregation process. Int J Mol Sci 21, https:\/\/doi.org\/10.3390\/ijms21197181 (2020).","DOI":"10.3390\/ijms21197181"},{"key":"25060_CR76","doi-asserted-by":"publisher","unstructured":"Filippini, A. et al. Extracellular clusterin limits the uptake of alpha-synuclein fibrils by murine and human astrocytes. Glia, https:\/\/doi.org\/10.1002\/glia.23920 (2020).","DOI":"10.1002\/glia.23920"},{"key":"25060_CR77","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00702-010-0462-z","volume":"117","author":"HP Vranova","year":"2010","unstructured":"Vranova, H. P. et al. CSF markers of neurodegeneration in Parkinson\u2019s disease. J. Neural Transm. 117, 1177\u20131181 (2010).","journal-title":"J. Neural Transm."},{"key":"25060_CR78","doi-asserted-by":"publisher","first-page":"E1821","DOI":"10.1212\/WNL.0000000000007315","volume":"92","author":"AS Buchman","year":"2019","unstructured":"Buchman, A. S. et al. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology 92, E1821\u2013E1830 (2019).","journal-title":"Neurology"},{"key":"25060_CR79","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin, D. J., Lee, V. M. Y. & Trojanowski, J. Q. Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat. Rev. Neurosci. 14, 626\u2013636 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"25060_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1738","volume":"3","author":"J Goedhart","year":"2012","unstructured":"Goedhart, J. et al. Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%. Nat. Commun. 3, 751 (2012).","journal-title":"Nat. Commun."},{"key":"25060_CR81","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"25060_CR82","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1110\/ps.04618904","volume":"13","author":"AM Catanzariti","year":"2004","unstructured":"Catanzariti, A. M., Soboleva, T. A., Jans, D. A., Board, P. G. & Baker, R. T. An efficient system for high-level expression and easy purification of authentic recombinant proteins. Protein Sci. 13, 1331\u20131339 (2004).","journal-title":"Protein Sci."},{"key":"25060_CR83","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/dbio.1997.8552","volume":"185","author":"CM Hedgepeth","year":"1997","unstructured":"Hedgepeth, C. M. et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82\u201391 (1997).","journal-title":"Dev. Biol."},{"key":"25060_CR84","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jmb.2009.03.065","volume":"388","author":"CC Rospigliosi","year":"2009","unstructured":"Rospigliosi, C. C. et al. E46K Parkinson\u2019s-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein. J. Mol. Biol. 388, 1022\u20131032 (2009).","journal-title":"J. Mol. Biol."},{"key":"25060_CR85","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1042\/bj3460577","volume":"346","author":"RA Furlong","year":"2000","unstructured":"Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A. & Rubinsztein, D. C. Alpha-synuclein overexpression promotes aggregation of mutant huntingtin. Biochem J. 346, 577\u2013581 (2000).","journal-title":"Biochem J."},{"key":"25060_CR86","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","volume":"30","author":"Y Durocher","year":"2002","unstructured":"Durocher, Y., Perret, S. & Kamen, A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30, E9 (2002).","journal-title":"Nucleic Acids Res."},{"key":"25060_CR87","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1073\/pnas.1218620110","volume":"110","author":"Z Li","year":"2013","unstructured":"Li, Z., Michael, I. P., Zhou, D., Nagy, A. & Rini, J. M. Simple piggyBac transposon-based mammalian cell expression system for inducible protein production. Proc. Natl Acad. Sci. USA 110, 5004\u20135009 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25060_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22108-0","volume":"12","author":"VA Trinkaus","year":"2021","unstructured":"Trinkaus, V. A. et al. In situ architecture of neuronal alpha-Synuclein inclusions. Nat. Commun. 12, 2110 (2021).","journal-title":"Nat. Commun."},{"key":"25060_CR89","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"25060_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14245-4","volume":"11","author":"R Imamoglu","year":"2020","unstructured":"Imamoglu, R., Balchin, D., Hayer-Hartl, M. & Hartl, F. U. Bacterial Hsp70 resolves misfolded states and accelerates productive folding of a multi-domain protein. Nat. Commun. 11, 365 (2020).","journal-title":"Nat. Commun."},{"key":"25060_CR91","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jmb.2014.04.018","volume":"426","author":"AJ Gupta","year":"2014","unstructured":"Gupta, A. J., Haldar, S., Milicic, G., Hartl, F. U. & Hayer-Hartl, M. Active cage mechanism of chaperonin-assisted protein folding demonstrated at single-molecule level. J. Mol. Biol. 426, 2739\u20132754 (2014).","journal-title":"J. Mol. Biol."},{"key":"25060_CR92","doi-asserted-by":"publisher","first-page":"16424","DOI":"10.1021\/bi991765q","volume":"38","author":"DK Wilkins","year":"1999","unstructured":"Wilkins, D. K. et al. Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 38, 16424\u201316431 (1999).","journal-title":"Biochemistry"},{"key":"25060_CR93","doi-asserted-by":"publisher","first-page":"e9344","DOI":"10.1371\/journal.pone.0009344","volume":"5","author":"C Banning","year":"2010","unstructured":"Banning, C. et al. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS ONE 5, e9344 (2010).","journal-title":"PLoS ONE"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25060-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25060-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25060-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:51:46Z","timestamp":1669971106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25060-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25060"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25060-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.16.452659","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4863"}}